Stemedica International Announces Joint Venture with AnC Bio Group to Manufacture Allogeneic Adult Stem Cells
Stemedica International, S.A., a wholly owned subsidiary of Stemedica Cell Technologies, Inc., announced the signing of an agreement to form a joint venture with AnC Bio, a global manufacturer of stem cell-based products. The new venture, StemedicaAnC, will manufacture allogeneic adult stem cells developed by Stemedica for the treatment of ischemic stroke and other degenerative disorders. - October 24, 2010
Stemedica Announces Completion of Clinical Allogeneic Adult Stem Cell Master Bank
A world leader in allogeneic adult stem cell manufacturing and research, Stemedica Cell Technologies, Inc. announced the completion of its proprietary master bank of mesenchymal bone marrow-derived stem cells. - October 15, 2010
Stemedica Announces the Appointment of Dr. Cesar Amescua Garcia as Medical and Regulatory Affairs Director – Latin America
Dr. Amescua will be responsible for liaison with regulatory agencies in Latin America regarding approvals of Stemedica’s allogeneic adult stem cell products for use in clinical (human) trials which follow the criteria required by the FDA in the United States. - July 02, 2010
The Allogeneic Adult Stem Cells Company Announcing Appointment of Dr. Lev Verkh
Lev Verkh is now a part of Stemedica, the allogeneic adult stem cells manufacturing company for effective stem cell clinical trials, thus improving the life of humans. - June 05, 2010